---
title: CLSA October Bulletin | 2019 State Legislative Year in Review & More!
---

 Read up on this year's state legislative in review, welcome new members, and catch up on CLSI updates.

| Not rendering correctly? View this email as a web page here.                         Connect with CLSA. New Members Please join us in welcoming the 21 new CLSA members who joined our trade association in October: Adamas Pharmaceuticals, Inc. \| Amunix Operating Inc. \| Argonaut Genomics, Inc. \| Arnold & Porter LLP \| BioIVT (Formerly Optivia Biotechnology) \|  Demonpore Inc. \| Immuno Concepts, Inc. \| Indie Bio \| New Culture Inc. \| Opiant Pharmaceuticals \| Palette Life Sciences, Inc. \| Pelian Biosciences, LLC \| Privo Technologies \| Protillion Biosciences \| Quadrants Scientific \| Ravel Biotechnology \| Recro Gainsville LLC \| Rejuvenation Technologies Inc. \| Sanverbos, Inc. \| Science and Medicine Group \| Zeno Pharmaceuticals Our membership portfolio grows ever more robust with the addition of these organizations, which add significantly to the expertise and resources available in the CLSA network. Advocate Federal Government Relations CLSA Leads Multi-State Organization Letter To Congressional Leadership Opposing International Reference Pricing Read More \>\> CLSA And Covington & Burling Host Member Roundtable With FDA’s Director Of The Office Of New Drugs (OND) In San Francisco Read More\>\> State Government Relations CLSA Helps Educate Members Of State Legislature With Life Sciences Company Tours At Allergan And Edwards Lifesciences Read More\>\> CLSA Op-Ed In CALMatters: California Leads The Way In Precision Medicine by Mike Guerra Read More\>\> Connect Explora Biolabs Adds Two Pre-Clinical Facilities to its Vivarium Network – One in San Francisco and One in San Diego Read More\>\> ClearLight Biotechnologies Signs an Exclusive License Agreement to Develop and Commercialize the CRYSTAL Technology, Invented at the University of Zurich and the University Hospital Zurich Read More\>\> CLSA Member Insights From King & Spalding: HHS Issues Proposed Rule To Update Anti-Kickback Statute Safe Harbors – What Does It Mean For Life Sciences Companies? Read More\>\> Sun Genomics Launches Breakthrough Solution To Deliver Personalized Probiotics In Only Six Weeks Read More\>\> Innovate CLSI’s FAST International Program Welcomes Australian And Canadian Startups And Emerging Companies Read More\>\> UC Berkeley Ups Its Commitment To Life Sciences Innovation Read More\>\> ARCS Foundation: 2019 Scholar Awards Celebration Read More\>\> FAST, Fellows And CARB-X Update October 2019 Read More\>\> About CLSA California Life Sciences Association (CLSA) is the state's largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, LinkedIn, and YouTube. Contact CLSA CALifeSciences.org \| Tel: (650) 871-3250 \| info@califesciences.org California Life Sciences Association \| 701 Gateway Boulevard South San Francisco CA \| Unsubscribe |
| --- |